Growing community of inventors

Pamplona, Spain

Josune Orbe Lopategui

Average Co-Inventor Count = 4.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Josune Orbe LopateguiJosé Antonio Páramo Fernández (2 patents)Josune Orbe LopateguiRosario Serrano Vargas (2 patents)Josune Orbe LopateguiJulen Oyarzabal Santamarina (1 patent)Josune Orbe LopateguiJosé Antonio Rodriguez Garcia (1 patent)Josune Orbe LopateguiJose Antonio Rodriguez Garcia (1 patent)Josune Orbe LopateguiJose Antonio Paramo Fernandez (1 patent)Josune Orbe LopateguiJóse Antonio Rodríguez García (1 patent)Josune Orbe LopateguiJulen Oyarzabal Santamarina (1 patent)Josune Orbe LopateguiJosé Antonio RODRÍGUEZ GARCÍA (0 patent)Josune Orbe LopateguiJosé Antonio Rodríguez García (0 patent)Josune Orbe LopateguiJosune Orbe Lopategui (3 patents)José Antonio Páramo FernándezJosé Antonio Páramo Fernández (2 patents)Rosario Serrano VargasRosario Serrano Vargas (2 patents)Julen Oyarzabal SantamarinaJulen Oyarzabal Santamarina (7 patents)José Antonio Rodriguez GarciaJosé Antonio Rodriguez Garcia (1 patent)Jose Antonio Rodriguez GarciaJose Antonio Rodriguez Garcia (1 patent)Jose Antonio Paramo FernandezJose Antonio Paramo Fernandez (1 patent)Jóse Antonio Rodríguez GarcíaJóse Antonio Rodríguez García (1 patent)Julen Oyarzabal SantamarinaJulen Oyarzabal Santamarina (4 patents)José Antonio RODRÍGUEZ GARCÍAJosé Antonio RODRÍGUEZ GARCÍA (0 patent)José Antonio Rodríguez GarcíaJosé Antonio Rodríguez García (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Proyecto De Biomedicina Cima, S.l. (3 from 17 patents)


3 patents:

1. 9440989 - Antifibrinolytic compounds

2. 8541370 - Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments

3. 8257701 - Methods for anti-fibrinolytic treatment using MMP-10 neutralizing antibody

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/18/2025
Loading…